Enveric Biosciences, Inc. (NASDAQ:ENVB – Get Free Report)’s share price traded down 3.9% during trading on Tuesday . The company traded as low as $1.62 and last traded at $1.74. 1,932,142 shares changed hands during trading, an increase of 472% from the average session volume of 337,854 shares. The stock had previously closed at $1.81.
Enveric Biosciences Price Performance
The firm has a 50-day moving average of $5.01 and a 200 day moving average of $6.42. The stock has a market capitalization of $1.18 million, a price-to-earnings ratio of -0.05 and a beta of 0.55.
About Enveric Biosciences
Enveric Biosciences, Inc, a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health.
See Also
- Five stocks we like better than Enveric Biosciences
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Rocket Lab’s Growth Strategy: Small Rockets, Massive Potential
- What is a support level?
- Goldman Sachs vs. Morgan Stanley—Which Stock Has More Upside?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- 3 Reasons Bulls Will Win on Super Micro Computer Stock
Receive News & Ratings for Enveric Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enveric Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
